TABLE 1 .
Demographic and pre-operative information for patients undergoing ONSF for IIH (n = 37).
Mean ± standard deviation | Range | |
---|---|---|
Age (years) | 33 ± 11 | 19–74 |
Gender | 5/37 (13%) male | |
Post-operative follow-up (weeks) | 210 ± 200 | 4–700 |
Unilateral/bilateral | 24 unilateral, 13 bilateral | |
Subsequent CSF diversion procedures | 8 (4 after second eye ONSF) | |
Time to surgery (weeks) | 36 ± 54 | 0.5–226 |
Time to second procedure (weeks) | 6 ± 7 | |
Clinical recurrence | 12/37 (32%) | |
Time to clinical recurrence (weeks) | 55 ± 56 | 5–375 |
Pre-operative steroids | 10/37 (27%) | |
Presenting symptoms | Headache: 35/37 (95%) | |
Pulsatile tinnitus 18/37 (49%) | ||
Transient visual obscuration 17/37 (46%) | ||
Diplopia 2/37 (5%) | ||
Pre-operative risk factors for IIH | Obesity 36/37 (97%) | |
Tetracycline 3/37 (8%) | ||
Obstructive sleep apnea 2/37 (5%) | ||
Oral contraceptive use 2/37 (5%) |